🔗 Share this article

An underground economy for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Vendors promote the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users administering products of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the platform has removed violative content and banned related hashtags and query recommendations. The company said it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Online Trading Operations

Research also found groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, positive reviews and detailed guides for mixing or injecting at home.

Within moments of joining one community, a vendor shared contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Inside these communities, messages display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Although the science behind this drug is valid, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially serious medical dangers”.